Tag: Covid 19 Vaccine

Covid-19-vaccine
India To Have Coronavirus Vaccine By 2020 End: Union Health Minister Harsh Vardhan

New Delhi: Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year. Speaking to reporters here, he said that a Covid-19 vaccine is likely in the next 4-5 months. “I hope that if everything goes well, […]

  • Tuesday, 13 April 2021
Sputnik V
Sputnik V Vaccine Authorized In India, 850 Million Doses To Be Produced Annually

New Delhi: The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has…

  • Tuesday, 13 April 2021
Health-Secy-Rajesh-Bhusan
COVID-19 Vaccine: India-Russia In Talks On Sputnik V, Initial Info Shared

New Delhi: The Centre said on Tuesday that India and Russia are in communication regarding the Sputnik V vaccine. While some initial information has been shared, detailed information is being awaited by India. Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology along with Russian Direct […]

  • Tuesday, 13 April 2021
COVID-Vaccine
IIT Alumni Council Says No To Covid Vaccine Plan

New Delhi: IIT Alumni Council has announced formal disbanding of the Covid vaccine initiative that was part of the six-month C19 Task Force. The vaccine team concluded that none of the available approaches and claims were adequately backed by disclosed scientific data, patient research and clinical studies. In addition to getting the vaccine paradigm right, […]

  • Tuesday, 13 April 2021
Astrazeneca
PGIMER To Begin Phase II Trial Of Oxford Covid-19 Vaccine Candidate

New Delhi: The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate — Covishield from the first week of September. The premier institute has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between […]

  • Tuesday, 13 April 2021
COVID-19-Vaccine
COVID-19 Vaccine: India Will Have 'Approved' Vax By 2021 Q1, Says Bernstein Research

New York: India is on course to have an “approved” vaccine within the first quarter of calendar year 2021 and Pune based Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, is well placed to deliver the first vaccine, according to a report out Thursday from Bernstein Research, a top Wall Street […]

  • Tuesday, 13 April 2021
Moderna-COVID-Vaccine
Covid-19 Vaccine: Moderna To Supply 40 Million Doses Of Vax To Japan

New York: The US-based biotech company Moderna has confirmed talks to supply 40 million doses of its potential Covid-19 vaccine to Japan. Under the terms of this arrangement, the vaccine, mRNA-1273, would be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical Co. Ltd. beginning in the first half of 2021, if the vaccine […]

  • Tuesday, 13 April 2021
Vaccine
COVID-19 Vaccine: US FDA May Fast Track Vax Before Phase-3 Trials End

New York: After Russia and China, the US drug regulator is now willing to consider giving emergency authorisation to a Covid-19 vaccine even before the end of crucial Phase-3 trials, according to the head of US Food and Drug Administration (FDA). In an interview with the Financial Times published on Sunday, FDA Commissioner Stephen Hahn […]

  • Tuesday, 13 April 2021
Covid-19-vaccine
Iran, Russia To Jointly Produce COVID-19 Vaccine

Cairo: Iran and Russia will cooperate to produce a COVID-19 vaccine in the Islamic republic as COVID-19 cases in Iran surged to 384,666 on Saturday. Meanwhile, an Iraqi health official warned that the citizens should not play down the seriousness of the coronavirus as 4,644 daily new infections were reported. Iran, the hardest-hit country in […]

  • Monday, 12 April 2021
Nigeria
UNICEF To Lead Global Procurement, Supply Of Coronavirus Vaccines

United Nations: In what could possibly be the world’s largest and fastest ever operation of its kind, UNICEF has announced that it will be leading the procurement and supply of coronavirus vaccines to ensure that all countries have safe, fast and equitable access to initial doses when they are available. The United Nations Children’s Fund […]

  • Monday, 12 April 2021
Sputnik-V-vaccine
Covid-19: Russia Produces First Batch Of Sputnik V Vaccine For Civilian Circulation

Moscow/New Delhi: In some good news for millions living in hope for a Covid-19 vaccine shot, the Russian Health Ministry said on Tuesday that the first batch of Sputnik V vaccine has been produced for civilian circulation. The supplies of the medication to the Russian regions are expected soon, the Health Ministry told reporters, reports […]

  • Monday, 12 April 2021
AstraZeneca
AstraZeneca COVID-19 Vaccine Study Halted After One Illness

New York: Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot. In a statement issued on Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data”. […]

  • Monday, 12 April 2021
Astrazeneca
DCGI Issues Notice To Serum Institute Over Oxford COVID-19 Vaccine Trial Suspension By AstraZeneca Abroad

New Delhi: The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine candidate for COVID-19 in other countries and also for not submitting casualty analysis of the “reported serious adverse events”. The show-cause […]

  • Monday, 12 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
COVID-19 Vaccine: Animal Study Proved Vax's Efficacy, Says Bharat Biotech

Hyderabad: Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model. “Bharat Biotech proudly announces the animal study results of COVAXIN – These results demonstrate the protective efficacy in […]

  • Monday, 12 April 2021
AstraZeneca
COVID-19 Vaccine: AstraZeneca Resumes Vax Trials In UK

New Delhi: Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. On September 6, the standard review process had triggered a voluntary pause to vaccination across all global trials to allow review of safety […]

  • Monday, 12 April 2021
scrollToTop